Dmi1 inverted phase contrast microscope
The DMi1 is an inverted phase contrast microscope manufactured by Leica. It is designed for routine microscopy tasks, providing a stable and reliable platform for various applications. The DMi1 employs phase contrast technology to enhance the visibility of transparent specimens, making it suitable for a range of sample types.
Lab products found in correlation
7 protocols using dmi1 inverted phase contrast microscope
Inverted Phase Contrast Microscopy Imaging
Inverted Phase Contrast Microscopy Imaging
HeLa Multicellular Tumor Spheroid Formation
spheroids (MTCS), 96-well Corning microplates with ultralow attachment
surface coating were used. Briefly, a single suspension of HeLa cells
at a density of 5 × 103 cells/well was prepared in
complete DMEM medium and dispensed into wells. The plates were covered
and transferred to incubator at 310 K with 5% CO2 atmosphere.
Within 3 days, uniform 200 μm diameter MTCS were formed from
cell suspension and were maintained under these conditions. At day
3, MTCS were incubated with tested agents (2 μM) for 6 h and
then irradiated with red light for 0.5 h. Treatments were then replaced
with fresh cell media and changed every 3 days by replacing 50% of
the media. The formation, integrity, diameter, and volume of the multicellular
tumor spheroids (MCTS) were monitored using a DMi1 inverted phase
contrast microscope (Leica Microsystems) over a span of 9 days.
Isolation and Preparation of hAF Cells
Multimodal Anti-cancer Treatment of MCTSs
× 103 cells/well in complete RPMI medium was dispatched
onto 96-well Corning microplates with ultralow attachment surface
coating. The plates were covered and transferred to an incubator at
310 K with a 5% CO2 atmosphere. After 3 days post-seeding,
uniform MCTSs were formed, which was confirmed using an inverted Zeiss
AXIO observer 7 microscope. Cell media of MCTSs was changed by replacing
50% with fresh cell media and allowed to grow for 3 days. On day 3,
MTCS was incubated with tested agents (10 μM) for 4 h and then
irradiated with 520 nm light for 1 h. Treatments were then carefully
removed, and fresh media was added. The integrity, radius, size, and
volume of the MCTSs were monitored using a DMi1 inverted phase contrast
microscope (Leica Microsystems) over 7 days. The radius of the tumorspheres
was measured using Fiji software, and the volume was calculated using
the following equation: V = 4/3πr3.
HeLa Multicellular Tumor Spheroid Formation
(MCTS), 96-well Corning
microplates with an ultralow attachment surface coating were utilized.
The process involved preparing a single suspension of HeLa cells at
a density of 5 × 103 cells per well in complete DMEM
medium, which was then dispensed into the wells. The plates were covered
and placed in an incubator with a temperature of 37 °C and a
5% CO2 atmosphere. Within 3 days, uniform MCTS with a diameter
of 200 μm were formed from the cell suspension and maintained
under these conditions. On the first day of treatment, the MCTS were
treated with
at their concentration of IC50. The media were changed
every 3 days by replacing 50% of the existing media. The formation,
integrity, diameter, and volume of the MCTS were monitored over a
span of 10 days using a DMi1 inverted phase contrast microscope (Leica
Microsystems). The volumes of the MCTS were calculated using the equation V = 4/3πr3, where “V″ represents volume and “r″ represents the radius of the MCTS measured with ImageJ software.
Isolation and Culture of hAF-MSCs
The hAF cell samples were observed under a DMi1 inverted phase contrast microscope (Leica Microsystems, USA). The cell samples that were collected from the 2nd passage were washed twice with sterile phosphate-buffered saline (PBS) (Amresco, Ohio, USA) and were trypsinized with 0.25% trypsin-EDTA. Subsequently, hAF cells were suspended in basal growth medium and centrifuged (C2 Series, Centurion Scientific Ltd, UK) at 2,035 g for 6 min at room temperature. After that, the supernatant was removed and the hAF cells were used in the experiments.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!